Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
In the United States, the overall costs related to chronic wounds are approximated to be 50 billion USD per year
UCSF neuroscientist Khaled Moussawi is now leading clinical work on GLP-1 drugs designed to target craving circuits, with potential applications across alcohol and opioid use disorder
CrossRef Association between peripheral IFN-+ cytotoxic lymphocytes and response to PD-1/PD-L1-based therapy in hepatocellular carcinoma Hui Lu, Huijuan Fang, Mengqi Ruan, Zhi Duang, Yan Wang, Wenwen Liu, Qin Wang, Qiang Zhou Frontiers in Immunology .2026;[Epub] CrossRef Poor prognostic factors in patients with intrahepatic cholangiocarcinoma undergoing anatomic hepatectomy Haisu Wang, Qingxiang Xu Asian Journal of Surgery .2026;[Epub] CrossRef PYCR1 Downregulation Induces Autophagy Dependent Apoptosis Through Inhibiting PI3K/AKT/mTOR Axis in Human Hepatocellular Carcinoma Cells Junli Zhang, Yachao Hou, Xinxin Jin, Biao Gu, Wenjuan Wu, Shih-Min Hsia Analytical Cellular Pathology .2026;[Epub] CrossRef Metabolic reprogramming and the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic targeting Zhao Ruan, Xuedan Sun Hepatoma Research .2026;[Epub] CrossRef The NPC1/USP7/p53 axis regulates cholesterol and promotes the proliferation of hepatocellular carcinoma Ru Deng, Xiaoming Zheng, Feihong Liu, Jing Gao, Shubin Wang, Jingping Yun, Feng Wang, Ying Li, Xixiong Ai, Yajie Liu Oncogene .2026
Unlike single-agonist peptides, this triple-acting formula provides a more comprehensive impact on metabolic functions
US$ 26.45
US$ 24.95
US$ 26.63
US$ 20.94
US$ 20.14
US$ 20.77
US$ 21.04
US$ 22.31
US$ 24.13
